Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?

Jones, Ronald N

Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)? [electronic resource] - Diagnostic microbiology and infectious disease Mar 2002 - 213-5 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0732-8893

10.1016/s0732-8893(01)00343-1 doi


Anti-Bacterial Agents--pharmacology
Ciprofloxacin--pharmacology
Drug Resistance, Bacterial
Drug Resistance, Multiple, Bacterial
Gram-Negative Bacteria--drug effects
Gram-Positive Bacteria--drug effects
Humans
Microbial Sensitivity Tests
United States
beta-Lactams